BioCentury | Mar 14, 2019
Company News

Orphan Drug designation for Espero's long-acting anticoagulant

...once daily. Espero Biopharma Inc. (Jacksonville, Fla.) said the compound is Phase III-ready. Elizabeth S. Eaton, Staff Writer tecarfarin (ati-5923) Espero Biopharma Inc. Vitamin...
Items per page:
1 - 1 of 1
BioCentury | Mar 14, 2019
Company News

Orphan Drug designation for Espero's long-acting anticoagulant

...once daily. Espero Biopharma Inc. (Jacksonville, Fla.) said the compound is Phase III-ready. Elizabeth S. Eaton, Staff Writer tecarfarin (ati-5923) Espero Biopharma Inc. Vitamin...
Items per page:
1 - 1 of 1